Grantham, Mayo, Van Otterloo & Co (GMO)
AGN

Grantham, Mayo, Van Otterloo & Co (GMO)’s Allergan plc AGN Stock Holding History

Grantham, Mayo, Van Otterloo & Co (GMO)’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-80,000
Closed -$15.2M – 609
2018
Q3 		$15.2M Buy
+80,000
New +$14.7M 0.1% 123

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $6.19B AUM 16.5% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

Grantham, Mayo, Van Otterloo & Co (GMO)'s AGN Position: Q2 2020 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 461,660 shares — an estimated $81.8M sold.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in AGN in Q4 2013 and held it in 12 quarters. The position peaked at $223M in Q3 2015. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Grantham, Mayo, Van Otterloo & Co (GMO) reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Grantham, Mayo, Van Otterloo & Co (GMO) sold 461,660 Allergan plc shares in Q2 2020, an estimated $81.8M.
  • Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in Allergan plc in Q4 2013 and held it in 12 quarters.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s Allergan plc position peaked at $223M in Q3 2015.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q2 2020, filed 13 Aug 2020.